A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT01686555 · COMPLETED
Trial details
- NCT number
- NCT01686555
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2015-06-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.